Search the webpage

Category: Cytotoxicity

An assessment and prediction of study compound-induced toxicity on the human retinoblastoma cells (WERI-Rb-1) in vitro.

SUMMARY

Cells

WERI-Rb-1 cells1-2 (RIKEN, Japan)

Exposure

Cells are exposed to study compounds at different concentrations for selected times (e.g. 4h, 24h)

Positive control

tert-butyl hydroperoxide (tBHP) at concentrations 0-30 mM

Indicator and detection

Indicator: resazurin (7-Hydroxy-3H-phenoxazin-3-one-10-oxide) dye is irreversibly reduced to highly fluorescent metabolite resorufin (7-Hydroxy-3H-phenoxazin-3-one);

 

Detection: after 2 h exposure to resazurin, the amount of resorufin is measured at 560 nm (ex), 590 nm (em) by using Cytation 3 multi-mode reader (BioTek Instruments, Winooski, VT, USA).

Please contact us, if you would like to receive more information: info@experimentica.com

IMAGES

Representative examples of assays on WERI-Rb-1 cells

Typical morphology of WERI-Rb-1 cells showing rosettes (R) and chain (C) formation. Scale bar 100 µm.

Characteristic grape-like glusters of WERI-Rb-1 cells at higher cell density. Scale bar 100 µm (left) and 200 µm (right).

SELECTED PUBLICATIONS

  • Campbell M, Chader GJ. Retinoblastoma cells in tissue culture. Ophthalmic Paediatr Genet. 1988 Nov;9(3):171-99. Review. PubMed PMID: 3068600.

REFERENCES

  1. McFall RC, Sery TW, Makadon M. Characterization of a new continuous cell line derived from a human retinoblastoma. Cancer Res. 1977,37(4):1003-1010.
  2. McFall RC, Nagy RM, Nagle BT, McGreevy LM. Scanning electron microscopic observation of two retinoblastoma cell lines. Cancer Res. 1978,38(9):2827-2835.

Leave a Comment

LATEST NEWS

Experimentica Ltd. Sponsors the 2018 SILK-Elsemay Björn Symposium

News
Experimentica Ltd. is pleased to announce its co-sponsorship and participation in this year’s SILK - Elsemay Björn Symposium. This yearly ... Read More

Check out our new publication on the mouse dry-eye disease model

An alpha1 adrenergic agonist shows preclinical efficacy in a preclinical model for dry eye syndrome ... Read More

Subscribe to Our Newsletter!

We promise that no sales pitches will be attached to newsletter. And don't worry, we hate spammers too!